Medicinal Chemistry Consultant Support Services
Closed Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- 75N95024Q00012
- Agency
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This combined synopsis and solicitation requests proposals for medicinal chemistry consultant support services. The National Institutes of Health seeks an experienced medicinal chemistry consultant on a part-time basis to provide technical guidance to drug discovery and development programs. Proposals are due by 1:00 pm ET on February 27, 2024 and shall be submitted electronically to the contracting officer. Proposals will be evaluated based on technical qualifications, past performance, and price/cost. The base period of performance is one year from March 2024 to February 2025, with two one-year option periods.
This requirement is set aside exclusively for small businesses. The place of performance will be within the United States. The contractor must comply with information security requirements to ensure computers storing government data meet encryption standards. The NAICS code is 541715 and PSC code is R425. The total contract value including options is estimated at $300,000.
Notice text
COMBINED SYNOPSIS / SOLICITATION COMPETITIVE
Title: Medicinal Chemistry Consultant Support Services
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested at this time and an additional written solicitation will NOT be issued. This acquisition is being conducted in accordance with the procedures of FAR Part 13 Simplified Acquisition Procedures and FAR Part 12 Acquisition of Commercial Items.
For additional details, please see attachment 8.
Attachments
| File | Type | Posted |
|---|---|---|
| D-CSS_75N95024Q00012_2.7.24(update offer due date).pdf | ||
| 8-CSS_75N95024Q00012_2.6.24.pdf | ||
| 3-FAR 52.212-4 Addendum.pdf | ||
| 5-Invoicing Instructions With IPP 3-23 (1).pdf | ||
| 6-Pricing.xlsx | XLSX spreadsheet | |
| 7-Evaluation Criteria.pdf | ||
| 2-FAR 52.204-26_Oct_2020.pdf | ||
| 4-FAR 52.212-5(Final).pdf | ||
| 1-FAR 52.204-24 (Nov 2021) (1).pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Medicinal Chemistry Consultant Support Services | Award Notice | |
| Medicinal Chemistry Consultant Support Services | Award Notice | |
| Medicinal Chemistry Consultant Support Services | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity